RecruitingPhase 4NCT07271420
Blood Pressure Control With Thiazide Diuretics in Peritoneal Dialysis Patients
Sponsor
Chinese University of Hong Kong
Enrollment
40 participants
Start Date
Jan 1, 2020
Study Type
INTERVENTIONAL
Conditions
Summary
To evaluate the blood pressure lowering effects of thiazide diuretics in patients on peritoneal dialysis
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- Patients on chronic peritoneal dialysis, with uncontrolled hypertension (SBP \>140 mmHg and/or DBP \>90 mmHg)
Exclusion Criteria1
- Patients with a life expectancy of less than 3 months, planned conversion to hemodialysis, or scheduled kidney transplantation within 3 months
Interventions
DRUGHydrochlorothiazide 25mg once per day
Thiazides diuretics
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07271420
Related Trials
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
NCT070644731153 locations
Sensor-based Congestion ALert for Events in Peritoneal Dialysis (SCALE-PD)
NCT070599624 locations
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
NCT0605963898 locations
OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP)
NCT052937561 location
Coaching and Navigation by Community Health Workers (CHWs) Through Telehealth for High-risk Hypertension
NCT074614154 locations